BioHealth News Archive
First pig-to-human heart transplant: what can scientists learn?
The first person to receive a transplanted heart from a genetically modified pig is doing well after the procedure last week in Baltimore, Maryland.…
Read More
Founder and Executive Chairman of Emergent BioSolutions Announces Retirement
GAITHERSBURG, Md., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Fuad El-Hibri, founder and executive chairman, has decided…
Read More
BioSpace: Cartesian Aims to Propel RNA Cell Therapy with Combinations
Published: Jan 07, 2022 By Gail Dutton Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon after diagnosis and address…
Read More
Institute for Bioscience and Biotechnology Research Receives $16.8M Investment from the National Institute of Standards and Technology
Fri, Jan 14, 2022 New Cooperative Agreement to Aid in the Development of Therapeutics and Vaccines, Improve Access to Medication The Institute…
Read More
Unblock research bottlenecks with non-profit start-ups
It takes more than a great idea to accomplish a great project. Our research and experience have convinced us that many worthy projects wither…
Read MoreCartesian Aims to Propel RNA Cell Therapy with Combinations | BioSpace
Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon after diagnosis and address a wide range of diseases beyond cancer. The…
Read More
South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine – Jan 12, 2022
-- Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine granted approval in South Korea GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ --…
Read More
Chain Drug Review Pharmacy Outlook: Ronald Piervincenzi, USP
January 10, 2022 by Ronald Piervincenzi The COVID-19 pandemic made the last year both an extraordinary and challenging time to work in health care.…
Read More
Decentralized Clinical Trials Raise Concerns About Informed Consent
Under pressure of the COVID-19 pandemic, multitudes of clinical trials of new medications and treatments have moved to a decentralized model, bringing them to…
Read More
REGENXBIO Announces Initiation of Second Pivotal Trial in RGX-314 Clinical Program for the Treatment of Wet AMD Using Subre…
ROCKVILLE, Md., Jan. 10, 2022 /PRNewswire/ -- ASCENTTM, a Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in…
Read More
MIMETAS opens Phenotypic Screening Center
Leiden, May 27, 2021 - MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center. The center facilitates large-scale…
Read More
Are we witnessing the dawn of post-theory science? | Artificial intelligence (AI) | The Guardian
Isaac Newton apocryphally discovered his second law – the one about gravity – after an apple fell on his head. Much experimentation and data…
Read More
Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research
- Partnership aims to drive innovation and clinical development of novel therapeutics for cancer treatment - ROCKVILLE, Md.--(BUSINESS WIRE)--Hibiscus BioVentures, a firm committed to…
Read More
A regional economic development strategy and why commercial real estate should care
The U.S. Economic Development Administration announced last month the winners of $500,000 planning grants to 60 jurisdictions across the country for the $1 billion…
Read More
NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
GAITHERSBURG, Md., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate…
Read More